This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Naoki Kanayama: Innovator in Antibody Selection Methods
Introduction
Naoki Kanayama is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of biotechnology, particularly in the methods for selecting antibody-producing cells. His innovative approach has the potential to enhance the efficiency of antibody production, which is crucial for various medical applications.
Latest Patents
Kanayama holds a patent for "Methods for specifically selecting antibody-producing cells." This patent outlines a process for selecting B cells that produce a desired antibody. The method involves culturing B cells that exhibit specific properties, including cell death induced under certain conditions. By utilizing a signal generated from the binding between an antigen and the antibody on the B cell surface, Kanayama's method allows for the selection of viable antibody-producing B cells that bind with the antigen.
Career Highlights
Throughout his career, Naoki Kanayama has focused on advancing the field of immunology and biotechnology. His work has led to the development of innovative techniques that improve the selection process for antibody-producing cells. This advancement is particularly important for research and therapeutic applications in medicine.
Collaborations
Kanayama has collaborated with notable professionals in his field, including Hitoshi Ohmori. These collaborations have contributed to the refinement and application of his patented methods, further enhancing their impact in the scientific community.
Conclusion
Naoki Kanayama's contributions to the field of antibody selection represent a significant advancement in biotechnology. His innovative methods have the potential to improve the efficiency of antibody production, which is vital for medical research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile